Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,550 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

for
Healthy Volunteers (HV)
Location: Glendale CA
Sponsor: Jade Biosciences, Inc.

Sex: All

Age: 18 - 55

Code: NCT07525947

Phase1, Recruiting

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

for
High Grade Sarcoma, Sarcoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 0+

Code: NCT07650656

Phase2, Recruiting

AV-101 Alone and in Combination With Probenecid in Healthy Subjects

for
Drug Drug Interaction
Location: Glendale CA
Sponsor: VistaGen Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT05280054

Phase1, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Beverly Hills CA, Fountain Valley CA, Bullhead City AZ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Long Beach CA, Westminster CA, Orange CA,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

for
Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)
Location: Torrance CA, Northridge CA, Las Vegas NV, Redmond WA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 45 - 70+

Code: NCT07613294

Phase3, Recruiting

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

for
Advanced Colon Adenocarcinoma,
Location: South Pasadena CA, Duarte CA, Long Beach CA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07595874

Phase2, Recruiting

Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)

for
Actinic Keratosis (AK)
Location: Manhattan Beach CA, Charleston SC
Sponsor: Avant Health LLC

Sex: All

Age: 18+

Code: NCT07657988

Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Beverly Hills CA, Koreatown CA, Los Angeles CA,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase2, Recruiting

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07040982

Phase1, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA, Los Angeles CA, Orange CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

In-patient SCC TMS

for
Major Depressive Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 65

Code: NCT05645575

Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

for
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder,
Location: Long Beach CA, Orange CA, Chino CA, Redlands CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07105111

Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase2, Recruiting

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Riverside CA, Culver City CA, Garden Grove CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07105098

Phase3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Riverside CA, Las Vegas NV, Palo Alto CA, Portland OR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Beverly Hills CA, San Antonio TX, Margate FL
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase1, Phase2, Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: Los Angeles CA, Portland OR, Seattle WA, Houston TX,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase2, Recruiting

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for
Non-small Cell Lung Cancer
Location: Beverly Hills CA, Bakersfield CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06345729

Phase3, Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Los Angeles CA, Fountain Valley CA, Reno NV,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06899126

Phase3, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles